Nov 9, 2023 04:01PM
Sep 8, 2023 06:16PM
Sep 6, 2023 09:00PM
Sep 1, 2023 09:00PM
Aug 27, 2023 09:00PM
Aug 19, 2023 05:52PM
Aug 10, 2023 04:05PM Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Aug 8, 2023 06:06PM
Jul 27, 2023 11:27AM
May 30, 2023 08:31AM
May 30, 2023 08:30AM
May 22, 2023 08:02AM
May 22, 2023 08:00AM
May 11, 2023 04:05PM Rain Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Progress
Mar 9, 2023 04:05PM
Jan 23, 2023 08:00AM
Jan 23, 2023 08:00AM
Nov 10, 2022 04:05PM
Nov 4, 2022 07:55AM
Nov 4, 2022 07:55AM
Aug 4, 2022 04:05PM Rain Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
Aug 4, 2022 10:47AM
Aug 4, 2022 08:00AM
Aug 4, 2022 08:00AM
May 4, 2022 04:01PM
Mar 3, 2022 04:05PM
Jan 5, 2022 08:00AM
Nov 19, 2021 08:00AM Rain Therapeutics Doses First Patient in Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)
Jun 3, 2021 08:12AM
Jun 3, 2021 08:00AM
Jun 2, 2021 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All